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Abstract
Background: Previous studies have demonstrated that DC differentially regulate influenza A virus (IAV)–specific CD8 T cell
responses in vivo during high and low dose IAV infections. Furthermore, in vitro infection of DC with IAV at low versus high
multiplicities of infection (MOI) results in altered cytokine production and a reduced ability to prime naı ¨ve CD8 T cell
responses. Flow cytometric detection of IAV proteins within DC, a commonly used method for detection of cellular IAV
infection, does not distinguish between the direct infection of these cells or their uptake of viral proteins from dying
epithelial cells.
Methods/Principal Findings: We have developed a novel, sensitive, single-cell RT-PCR–based approach to assess the
infection of respiratory DC (rDC) and lymph node (LN)-resident DC (LNDC) following high and low dose IAV infections. Our
results show that, while a fraction of both rDC and LNDC contain viral mRNA following IAV infection, there is little
correlation between the percentage of rDC containing viral mRNA and the initial IAV inoculum dose. Instead, increasing IAV
inoculums correlate with augmented rDC MOI.
Conclusion/Significance: Together, our results demonstrate a novel and sensitive method for the detection of direct IAV
infection at the single-cell level and suggest that the previously described ability of DC to differentially regulate IAV-specific
T cell responses during high and low dose IAV infections could relate to the MOI of rDC within the LN rather than the
percentage of rDC infected.
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Introduction
Following influenza A virus (IAV) infection, respiratory dendritic
cells (rDC) mature, upregulate costimulatory molecules, and
migrate to the regional lymph nodes (LN) where they participate
in the induction of virus-specific CD8 T cell responses [1,2,3].
Importantly, the signals provided to naı ¨ve CD8 T cells through DC
interactions and thecorrespondingcytokine environmentwithinthe
LN are known to shape the type of T cell response generated. For
example, IL-12p70 has been shown to promote increased CD8 T
cell survival, CD25 upregulation and cytolytic activity [4,5,6].
Because of their essential role in regulatingthe induction of adaptive
immune responses, it is not surprising that migratory rDC and
LNDC have been implicated as key players in governing the
phenotype and magnitude of adaptive immune responses following
lethal vs. sublethal dose IAV infections.
Previous studies have shown that in vitro infection of bone-
marrow derived DC [7,8,9] or isolated murine respiratory DC
[10] with IAV can influence subsequent DC cytokine production
and priming of virus-specific CD8 T cell responses. Interestingly,
while IAV infection of BMDC at low multiplicities of infection
(MOI) resulted in enhanced CD8 T cell responses following in vitro
stimulation, high MOI resulted in blunted CD8 T cell responses,
increased IL-12p40 production [8] and increased production of
the anti-inflammatory cytokines IL-10 and TGF-beta [9].
Additionally IAV infection of pulmonary rDC at high, but not
low MOI, resulted in increased production of IL-6, MIP-1a and
IFNa by certain DC subsets [10].
Similar to these in vitro studies, we have demonstrated that rDC
and LNDC produce an increased concentration of IL-12p40
during a high-dose IAV infection setting that results in LNDC-
mediated killing of CD8 T cells, a blunted virus-specific CD8 T
cell response in the lungs, and ultimately, a lethal outcome [11].
Further, we and others have demonstrated that IAV protein
expression could be detected by flow cytometry in rDC that have
migrated from the lungs to the LN following both high and low
dose infections, but not on LNDC in either infection setting
[10,11,12]. Importantly, the frequency and MFI of those cells
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and nonstructural-1 protein (NS-1) is increased in mice receiving
lethal doses of IAV relative to those receiving sublethal doses of
infection [10,11]. These results suggested that the increased viral
infection of migratory rDC in lethal infection settings may play an
important role in regulating the ensuing adaptive CD8 T cell
response and ultimately, disease outcome.
The flow cytometry-based method of detection of IAV proteins
in DC is particularly valuable due to the high-throughput nature
of the analysis and the ability to examine very small populations of
infected cells. However, flow cytometry lacks sufficient sensitivity
to quantify viral load or discern infected cells from those that have
taken up viral antigens. Additionally, if the migratory rDC are
indeed directly infected during low and high dose settings, it is
impossible to quantify the amount of virus infecting each cell.
Given the hypothesized importance of MOI in regulating DC
function and ability to promote robust CD8 T cell responses
[7,8,9,10], we assessed DC infection by a more sensitive and
quantitative approach. PCR for viral mRNA has been previously
used to detect viral infection on bulk tissues such as the mediastinal
lymph nodes and lungs [13,14,15]. Therefore we used single cell
RT-PCR [16,17] to detect the presence of viral mRNA,
particularly spliced mRNA from IAV genes, in individual DC.
This technique may more accurately define direct IAV infection as
the spliced mRNA should have a short half-life and only be
expressed during active viral replication. Further, by monitoring
the PCR cycle threshold during the RT-PCR analysis, one should
be able to estimate the relative viral load of the infected cells. Our
results show that a fraction of rDC and LNDC contain viral
mRNA following both high and low dose IAV infections, and that
the frequency of IAV mRNA+ DC present within the LN does not
correlate with the increasing viral inoculum. Instead, we
demonstrate that relative mRNA load per cell correlates with
increasing initial viral inoculum, particularly within the migratory
rDC subset. Together, these results suggest that in vivo rDC
infection and hence, the magnitude of adaptive responses and
outcome of disease, may depend on the multiplicity of infection
(MOI) of migratory rDC.
Results
Comparison of IAV protein and mRNA expression in in
vitro IAV-infected XS106 DC
In order to compare single-cell RT-PCR analysis to flow
cytometry analysis for IAV proteins, we initiated experiments
using the DC-like cell line XS106. XS106 cells were infected in
vitro with increasing MOI of the IAV. At 18 hours p.i., the cells
were harvested and analyzed by flow cytometry for IAV proteins
(Fig 1A) or by single-cell RT-PCR for presence of IAV NS2
mRNA (Fig 1B and C). Not unexpectedly, the frequency of XS106
cells with detectable IAV HA and NP proteins (Fig 1A, top panels)
or influenza NP and NS1 proteins (Fig 1A, bottom panels) by flow
cytometry was proportional to the MOI, with approximately 13%
of cells expressing IAV proteins following a 10.0 MOI infection
and approximately 1% of cells expressing IAV proteins following a
0.1 MOI infection (Fig 1A). In contrast, when cells were analyzed
by single cell RT-PCR analysis for influenza NS2 mRNA, we
observed that over 90% of the XS106 cells expressed viral mRNA
following a 10 MOI infection and at least 2% of the cells still
expressed viral mRNA even after a 0.01 MOI infection (Fig 1B).
Importantly, the primers for detecting viral mRNA expression
were specific and did not display cross-reactivity, as we observed
no amplification of bands in uninfected cells. In addition to the
correlation between decreasing frequencies of infected cells and
decreasing MOI, we also observed a correlation in the band
intensity and MOI (Fig 1C). While cells infected at a 0.01 MOI
showed only a faint band for NS2 mRNA expression (0.068
intensity relative to cyclophilin), those infected at a 10 MOI
showed a more intense band (0.865 intensity relative to
cyclophilin), suggesting increased viral loads in cells infected at
high MOI relative to those infected at low MOI. Together, these
results demonstrate that single cell RT-PCR for IAV mRNA
expression is more sensitive than results obtained using flow
cytometry and that this method can be successfully applied to
detect relative viral loads between infected cells.
Infection of migratory rDC and LNDC following high and
low dose IAV infections as measured by RT-PCR
We next utilized the single-cell PCR methodology to examine
infection of migratory rDC and LNDC in high and low dose in vivo
IAV infections. To this end, BALB/c mice were treated intranasally
(i.n.) with CFSE to specifically label the DC present in the lungs. Six
hours later, the mice were infected with increasing inoculums of
IAV and at 18 hours post infection (p.i.), CFSE
+CD11c
+MHC-II
+
migratory rDC and CFSE
negCD11c
+MHC-II
+ LNDC were FACS
purified from the pooled draining LN and analyzed by RT-PCR for
IAV NS2 mRNA expression. In agreement with previous results
obtained by flow cytometry for IAV proteins [10,11], we observed
IAV mRNA in migratory CFSE
+CD11c
+MHC-II
+ rDC at both
high and low inoculum doses (Fig 2A). Interestingly, however, while
previous flow cytometry results have suggested a correlation
between the IAV inoculation dose and the frequency of rDC that
expressed IAV proteins, we instead observed that a similar
frequency (5–7%) of CFSE
+ rDC were infected at the 10, 1 and
0.1 LD50 inoculum doses by RT-PCR analysis. However, at a very
low inoculum dose of virus (i.e. a 0.01 LD50 dose), there was a
decreased level of infection of CFSE
+ rDC, with only 1% of rDC
expressing viral mRNA (Figure 2A). In further contrast with the
resultsobtained usingflowcytometryforviralproteinssuggestingno
infection of LNDC [11], the more sensitive single-cell RT-PCR
approach revealed that a small fraction of CFSE
neg LNDC were
IAV NS2 mRNA
+, even at very low inoculum doses. Infection of
LNDC did not appear to correlate with inoculum dose, as ,1–2%
of LNDC are infected in both lethal (10 and 1 LD50 doses) and
sublethal (0.1 and 0.01 LD50 doses) infection settings (Fig 2A).
Together, these results suggest that while migratory rDC and
LNDC are infected during a primary IAV infection, there is little
correlation between thefrequency of infectionineithercell type and
the initial inoculum load.
Increased MOI in migratory rDC following high vs. low
dose IAV infections
Given the results of Oh et al. [9] suggesting that increasing MOI
can have adverse effects on the ability of DC to promote robust
adaptive CD8 T cell responses, we next utilized the single-cell RT-
PCR approach to compare the MOI of DC from low and high
dose IAV infections. To this end, we used increasing cycle
numbers to distinguish the level of IAV infection in migratory
CFSE
+ rDC from 10 LD50 vs. 1 LD50 infections. Strikingly, while
viral NS2 mRNA was detectable in rDC purified from a 10 LD50
dose infection setting after as few as 10 cycles (Fig 2C, left), it took
30 cycles to detect viral mRNA in rDC purified from a 1 LD50
dose infection setting (Fig 2C, right). Overall, these results suggest
that rDC from high dose infection settings may have been infected
with more IAV virions than rDC from lower dose infections.
These results further suggest that an increase in influenza MOI in
rDC following high vs. low dose infections may be key in
Influenza Infection of DCs
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[7,8,9,11].
Discussion
Here, we have developed a novel, sensitive, in vivo single-cell
RT-PCR approach for directly analyzing IAV infection of rDC
and LNDC following high and low dose infection. The RT-PCR
method of analysis offers several advantages over the previously
utilized flow cytometry approach. While the flow cytometry based
method allows one to detect the presence of IAV proteins, it lacks
the ability to discern between direct infection of DC and the
presence of IAV protein as a result of phagocytosing infected
epithelial cells. Given previously published results demonstrating
the significant effects of direct IAV infection on DC cytokine
production and the ability to prime adaptive T cell responses in
vitro, it is essential to understand the relationship between IAV
infection and DC function in vivo. Our newly described method of
single-cell RT-PCR detects spliced mRNA from the IAV NS2
gene, in individual DC. This technique more accurately defines
direct IAV infection as the spliced mRNA is expected to have a
short half-life, is only expressed during active viral replication, and
is present a much reduced levels compared to the IAV NP and HA
proteins used for flow cytometry-based detection [18]. Paired with
complimentary analysis for cytokine and chemokine mRNA, the
single-cell RT-PCR approach may prove very powerful for
studying the results of direct infection on DC function and the
resulting adaptive immune response in vivo.
As a further advantage over the current flow cytometry based
method of IAV protein detection, the single-cell RT-PCR
approach also offers increased sensitivity and the ability to
quantitate the amount of virus load per cell. Previously utilized
Figure 1. Single cell RT-PCR and flow cytometry following increasing MOI in the dendritic-like cell line XS106. XS106 cells were
infected with 0, 0.01, 0.1, 1 and 10 MOI of IAV. 18 hours p.i., cells were harvested and analyzed by flow cytometry (A) for the IAV proteins
hemagglutinin (HA) and nucleocapsid protein (NP) (top panels) or HA and nonstructural-1 (NS-1) (bottom panels) or (B and C) single-cell PCR for the
viral nonstructural protein 2 (NS-2) mRNA. Data are representative of 2 separate experiments. Cyclophilin normalized intensities in C; 0.865: 10 MOI;
0.640: 1MOI; 0.388: 0.1MOI; 0.068: 0.01MOI.
doi:10.1371/journal.pone.0012902.g001
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following high dose (i.e. 1 and 10 LD50), but not low dose (i.e. 0.1
LD50) IAV infection [11]. Further, the flow cytometry based
analysis did not detect the presence of IAV infection in LNDC
[11]. In contrast, our results using the more sensitive single-cell
RT-PCR based method demonstrate that IAV mRNA is present
in both migratory rDC and LNDC in vivo following both high and
low dose infection. We further demonstrate that, in direct contrast
to those results obtained using the flow cytometry based method of
detection [11], a similar frequency of rDC (5–7%) and LNDC (1–
2%) are infected in vivo following either high or low doses of
infection. The single-cell RT-PCR approach also allows one to
quantitate the viral load per cell. We demonstrate here that the
MOI of migratory rDC differs significantly with respect to the
initial viral inoculum (Figure 2B). Interestingly, at high doses of
infection, results from the flow cytometry based method correlate
well with the results from the RT-PCR based method: increasing
viral inoculum results in increased MFI by flow cytometry
(Figure 1A and [11]) or increased MOI by RT-PCR (Figure 1C
and 2A). However, with lower doses of infection (i.e. 0.1 LD50 or
less), the MFI by flow cytometry is below the limit of detection
while the more sensitive RT-PCR method still detects the presence
of viral mRNA, indicative of DC infection, and a difference in the
quantity of viral load per cell. Together, these results suggest that
while the flow cytometry based method is invaluable for its high-
throughput nature and ability to study very rare populations of
cells directly ex vivo, our novel single-cell PCR based method is
more accurate and sensitive for the detection and quantification of
direct viral infection and will prove essential for determining the
effects of direct infection on DC function in vivo.
At this time, the source of IAV mRNA in CFSE
neg LNDC
remains unclear. We have previously demonstrated that the i.n.
CFSE labeling technique labels all cell types present in the
respiratory tract, and results in little to no non-specific labeling of
cells in the draining LN [1]. Therefore, it is unlikely that the
CFSE
neg DC are unlabeled cells that traveled from the lungs to the
LN. It is possible that LNDC obtained IAV mRNA through the
phagocytosis of infected rDC that migrated from the lungs to the
LN following infection. However, given the low frequency of IAV
mRNA positive cells in the LN, and the technical difficulty
associated with sorting very rare populations of DC, this could also
be an artifact resulting from cell sorting contamination. Future
studies should be aimed at confirming if direct infection of LNDC
occurs in vivo following high and low dose infections and, if so, how
this alters the priming of adaptive immunity therein.
It is known that the magnitude of the adaptive response shares
an inverse correlation with the initial viral inoculum [11]. Direct
infection of DC with low MOI in vitro results in significant
production of pro-inflammatory cytokines and priming of a robust
CD8 T cell response, while infection of DC with a high MOI
results in increased production of anti-inflammatory cytokines
such as IL-10 and TGF-beta, and a reduced ability to prime CD8
T cell immunity [9]. Together these results along with the results
herein demonstrating that increasing doses of IAV result in
increased MOI of migratory rDC suggest that the magnitude of
rDC infection may be a key feature in the regulation of adaptive
CD8 T cell responses following lethal vs. sublethal IAV infections
in mice.
Materials and Methods
Ethics Statement
Experiments were conducted according to federal and institu-
tional guidelines and all animal experiments were approved by the
University of Iowa Animal Care and Use Committee (Protocol #s:
0611238, 0911255).
Mice
Female BALB/c mice were purchased from the National
Cancer Institute (Frederick, MD) and used for experiments at 6–8
weeks of age. Mice were allowed access to food and water ab
libitum. Mice were housed and maintained under specific-pathogen
free conditions in the animal care facility at the University of Iowa.
All animals were handled in strict accordance with good animal
practice as defined by the relevant national and/or local animal
welfare bodies, and all animal work was approved by the
University of Iowa Animal Care and Use Committee.
Tissue Culture
NS46/47 fibroblast cell lines and XS106 dendritic cell lines
were a kind gift from Dr. Akira Takashima (University of Toledo)
[19,20,21]. NS46/47 fibroblast feeder cell lines were grown in
complete RPMI and the supernatant was collected and filter
sterilized. XS106 A/J derived dendritic cell line was maintained in
Figure 2. Single cell RT-PCR following increasing inoculum
doses. BALB/c mice were treated i.n. with CFSE. 6 hours later, groups of
mice (20 mice/group) were left uninfected (Naı ¨ve) or infected with the
indicated dose of IAV. At 18 hours p.i., draining LN (20 mice/group)
were pooled and migratory rDC (CFSE
+CD11c
+MHC II
+) and LNDC
(CFSE
negCD11c
+MHC II
+) were single-cell FACS sorted into 96 well plates
and analyzed by single-cell RT-PCR for expression of viral NS-2 mRNA as
described in Materials and Methods. (A) Data represent the frequency of
NS-2 IAV mRNA
+ cells/total cells analyzed. (B) cDNA from positive
samples in (A) was again amplified by nested PCR for NS2. Indicated is
the cycle at which the PCR reaction was stopped during the second
nested PCR reaction (i.e. the amplification with the NS2C:NS3 primers).
doi:10.1371/journal.pone.0012902.g002
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and 0.5 ng/ml mouse recombinant GM-CSF.
Intranasal CFSE administration
Intranasal CFSE administration was performed 6 hours prior to
influenza virus infection. Mice were anesthetized by isofluorane
inhalation and administered 50 ml of 8 mM CFSE diluted in
Iscove’s DMEM as previously described [1].
Influenza Virus Infection
Viruses were grown in 10 day old embryonated hen eggs, snap
frozen and stored at 280uC as previously described [11]. XS106
cells were washed and suspended in serum-free RPMI. Mouse-
adapted A/JAPAN/305/57 (H2N2) was then added to the culture
and incubated to 30 minutes on ice, followed by 30 minutes at
37uC. Following infection, the cells were washed, returned to
complete RPMI and cultured at 37uC for 18 hours prior to flow
cytometry staining or single-cell PCR. Mice were anesthetized by
isofluorane inhalation and infected i.n. with either a 10 LD50
(3.67610
6 EIU) (lethal dose, 100% lethality), 1 LD50 (3.67610
5
EIU) (lethal dose, ,50% lethality), 0.1 LD50 (3.67610
4 EIU)
(sublethal dose, ,5% lethality) or 0.01 LD50 (3.67610
3 EIU)
(sublethal dose, ,1% lethality) dose of mouse-adapted A/JAPAN/
305/57 (H2N2) in 50 ml of Iscove’s media.
Staining for Influenza Viral Antigen
XS106 A/J derived dendritic cell line cells were infected and
harvested 18 hours p.i. Cells were fixed in BD FACS Lysing
solution (BD Biosciences), permeabilized with 0.5% saponin and
stained with antibodies to influenza Nucleoprotein (NP) antigen
(clone H16, kindly provided by Walter Gerhardt, Wistar Institute),
influenza hemagglutinin antigen (clone Fc125) or non-structural
protein 1 (NS-1) antigen (clone 1A7, kindly provided by Jonathan
Yewdell, NIAID) for 30 minutes at 4uC. All flow cytometry data
was acquired on a BD FACS Calibur (BD Immunocytometry
Systems) in CellQuest (BD) and analyzed using FlowJo software
(TreeStar, Ashland, OR).
Preparation of Lymph Node (LN) Dendritic Cells for
single-cell RT-PCR
CFSE-labeled, IAV infected mice were harvested 18 hours p.i.
Draining mediastinal and peribronchial LN were harvested,
pooled and single cell suspensions were prepared. Cells were
labeled with rat anti-mouse IA/IE (M5/114.15.2) and hamster
anti-mouse CD11c (HL3) (both purchased from Becton Dickinson)
for 30 minutes at 4uC. CD11c
+MHC II
+ cells were first sorted for
bulk yield (Figure S1A), then single cells were subsequently sorted
into 96 well plates based on CFSE positivity (Figure S1B). Sorting
was performed on a BD FACS Diva (BD Immunocytometry
Systems) that is equipped with three excitation sources: an Argon
ion laser at 475.9 nm, 488 nm or 514.5 nm, a dye laser at 600 nm
and a Krypton laser at 337.5–356.4 nm (UV) or 406.7 nM (violet);
and has the ability to run 11 channels plus time.
Single-Cell RT-PCR
The protocol for single cell RT-PCR was modified from
[16,17]. Single cells were sorted into a premix detergent
containing OligoDT (Integrated DNA Technologies), 10% NP-
40 (Sigma), 0.1 M DTT (Invitrogen) and rRNase OUT (Invitro-
gen), then stored at 280uC until use. cDNA synthesis was
performed using the Reverse Transcription System (Promega)
according to manufacturers instructions.
The following primers were ordered from Integrated DNA
Technologies for PCR: Cyclophilin 1 Forward: GTGGTCTTT-
GGGAAGGTGAA; Cyclophilin 2 Reverse: TTACAGGACATT-
GCGAGCAG; Cyclophilin A Forward: GGCCGATGACGAG-
CCC; NS2A Forward: GATCCCAACACTGTGTCAAGC; NS5
Reverse: CGAGAAAGTTCTTATCTCTTGTTCC; NS2C For-
ward: CACTGTGTCAAGCTTTCAGGAC; NS3 Reverse: CT-
TCTTCAATCAGCCATCTTATTTC. All PCR amplifications
used Red Hot Taq (AbGene), dNTPs (Invitrogen), 10X PCR
butter and MgCl2 (ThermoScientific). Prior to amplification, all
cDNA was diluted 1:5. Amplification of Cyclophilin was
performed by nested PCR as follows: round 1 using Cyclophilin
1 Forward and Cyclophilin 2 Reverse for 40 cycles (94uC for 30
seconds, 52.4uC for 30 seconds, 72uC for 2 minutes); round 2 using
Cyclophilin A Forward and Cyclophilin 2 Reverse for 30 cycles
(94uC for 30 seconds, 52.4uC for 30 seconds, 72uC for 2 minutes).
Amplification of influenza NS2 mRNA was performed by nested
PCR as follows: round 1 using NS2A Forward and NS5 Reverse
for 40 cycles (94uC for 30 seconds, 59uC for 30 seconds, 72uC for 2
minutes); round 2 using NS2C Forward and NS3 Reverse for 45
cycles (94uC for 30 seconds, 57uC for 30 seconds, 72uC for 2
minutes). Samples were then run on a 1.5% Agarose gel. All
positive samples were confirmed by a second PCR reaction from
the remaining cDNA.
Supporting Information
Figure S1 Single-cell sorting scheme. Single-cell sorting was
performed in two steps. (A) An initial dendritic cell enrichment sort
was performed on draining lymph node cells, enriching for
CD11c
+MHCII
+ cells. Enrichment increased DCs from 0.93% (A)
to 45.1% (B). (B) The enriched population was then sorted into 96
well plates containing lysis buffer based on CD11c
+MHCII
+
expression and divided into two populations, CFSE
+ and CFSE
neg.
Found at: doi:10.1371/journal.pone.0012902.s001 (1.55 MB TIF)
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